alexa Metformin Therapy In Iraqi Women With Polycystic Ovary Syndrome: Serum Anti-mullerian Hormone Assessment
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd World Congress on Cancer Science & Therapy
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Basil O. Saleh, Wasan F. Ibraheem and Nada S. Amin
Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.030
Abstract
Background:The Polycystic ovary syndrome (PCOS) is established in the presence of two of the three following criteria: clinical and / or biochemical hyperandrogenism, chronic oligo-anovulation and polycystic ovarian morphology in ultrasound. Long- term metformin treatment may increase ovulation, improve menstrual cyclicity, and decrease androgen levels in these patients. Aim: The aim of this study was to investigate the effectiveness of short and long term metformin treatment in Iraqi PCOS women and the role of anti-mullerian hormone (AMH) levels in assessment of this treatment. Subjects and Methods: This study was carried out at biochemistry department, college of medicine, University of Baghdad, Iraq. It included twenty PCOS women aged (18-38 year) studied on cycle day (cd) from 2-4 (group I). These women were followed up after they were used metformin hydrochloride tablet 500 mg three times daily for 3 months (and considered as group II). Moreover, 18 PCOS women aged (22-36 year) who were already on metformin hydrochloride treatment 500 mg tablet three times daily for 6 months to 3 years and was studied on cd 2-4 ( and considered as group III). Serum investigations included measurements of AMH, FSH, LH, Free Testosterone, E2, prolactin and 17- alpha hydroxyprogesterone. Furthermore, ultrasonic study included ovarian volume and number of ovarian follicles was also studied. Results: The mean (?SEM) value of serum AMH levels was significantly decreased in group II with short term metformin treatment when compared with that of Group I PCOS women before treatment (P<0.01). In addition, the mean of serum AMH levels of group II was insignificantly reduced in comparison with that of Group III long term treatment (P>0.05). However, there was no significant difference in serum AMH mean value between Group I and Group III. Conclusions: This study revealed the effectiveness of three months short term metformin treatment in Iraqi PCOS women and the efficacy of serum AMH measurement in evaluation of this treatment. Long term metformin treatment of more than 3 months has no advantage over that of short treatment in correction of PCOS condition. Keywords: PCOS, metformin hydrochloride, AMH.
Biography
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version